相关实验视频

Updated: May 7, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

分析STEMI患者的禁食血糖水平与根西尼得分之间的非线性关系

Han Li¹, Quanzhi Lin², Zhiyuan Jiang¹

¹Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Frontiers in cardiovascular medicine

|January 3, 2025

概括

低血糖和高血糖都与ST段升高心肌梗塞患者的严重冠状动脉疾病有关. 这种U形的关系凸显了在STEMI护理中需要仔细管理葡萄糖的需要.

科学领域:

心脏病学心脏病学
内分泌学在内分泌学.
代谢综合征是代谢综合征的一种.

背景情况:

ST段升高心肌梗塞 (STEMI) 是一个主要的全球健康问题.
糖尿病 (DM) 是STEMI的一个重要风险因素.
根西尼分数量化冠状动脉病变的严重程度,但其与STEMI患者的空腹血糖 (FBG) 的非线性关系需要进一步调查.

研究的目的:

调查ST段升高心肌梗塞 (STEMI) 患者的禁食血糖 (FBG) 水平和冠状动脉病变严重程度之间的非线性关系,用Gensini评分测量.
为了确定低血糖和高血糖是否与STEMI患者的Gensini分数增加有关.

主要方法:

分析了464名接受皮肤冠状动脉干预的STEMI患者的数据.
患者的分层分为三个FBG第三层.
应用统计分析,包括LASSO回归和曲线拟合,以评估FBG-Gensini得分关系.

主要成果:

在FBG第三种动物中观察到Gensini分数的显著差异.
低血糖和高血糖极端都与较高的根西尼分数相关,而不是正常血糖范围.
曲线拟合证实了FBG水平与冠状动脉病变严重程度之间的显著U形,非线性关联,无论糖尿病状况如何.

结论:

低血糖和高血糖都是STEMI患者严重冠状动脉病变的显著危险因素,根據Gensini评分.
全面的FBG监测和管理对于改善STEMI患者的治疗结果至关重要.
这些发现强调了STEMI中血糖控制和心血管疾病严重程度之间的复杂相互作用.

关键词:

根西尼的得分是什么? 根西尼的得分是什么?ST升高心肌梗塞的心脏病发作剧烈的心肌梗塞急性心肌梗塞在糖尿病中,糖尿病是血糖类的.禁食血糖血糖禁食血糖血糖

更多相关视频

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

Analyzing Ex Vivo Metabolic Flux in Splenic and Cardiac Macrophages and Bone Marrow Monocytes

Analyzing Ex Vivo Metabolic Flux in Splenic and Cardiac Macrophages and Bone Marrow Monocytes

Published on: March 28, 2025

相关概念视频

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...